ANIP : Insider Transactions for ANI Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

ANI Pharmaceuticals Inc (ANIP)

$67.25

0.14 (0.21%) as of 4:30 Fri 5/3

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

20,430,000

Market Cap:

1.37(B)

Last Volume:

2,387,520

Avg Vol:

2,380,888

52 Week Range:

$38.04 - $69.69

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

AMEX COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year


Company Profile ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	254,921	421,551	1,262,027	1,480,093
Total Sell Value	$16,747,919	$26,516,522	$74,515,877	$82,888,946
Total People Sold	8	9	12	12
Total Sell Transactions	23	40	87	90
End Date	2024-03-07	2023-12-05	2023-06-06	2022-06-06

Adjust Filter Settings

Records found: 722

Page 4 of 29

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

SR. VP, GENERAL COUNSEL & SEC.

• – –

2024-01-12

4

AS

$56.43

$14,108

D/D

(250)

37,049

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-12-19

4

AS

$52.65

$1,316,250

I/I

(25,000)

932,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-12-18

4

AS

$52.44

$683,083

I/I

(13,026)

957,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-12-15

4

AS

$52.44

$627,917

I/I

(11,974)

970,646

-

SR. VP, GENERAL COUNSEL & SEC.

• – –

2023-12-11

4

AS

$49.21

$12,303

D/D

(250)

37,299

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-17

4

AS

$51.00

$663,000

I/I

(13,000)

982,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-16

4/A

AS

$51.66

$333,104

I/I

(6,448)

995,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-16

4

AS

$51.66

$333,104

I/I

(6,448)

996,430

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-15

4/A

AS

$53.64

$410,185

I/I

(7,647)

1,002,068

-

SVP, CHIEF HR OFFICER

• – –

2023-11-15

4

S

$53.81

$141,090

D/D

(2,622)

32,587

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-15

4

AS

$53.64

$410,185

I/I

(7,647)

1,002,878

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-14

4/A

AS

$53.17

$1,217,859

I/I

(22,905)

1,009,715

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-11-14

4

AS

$53.17

$1,174,791

I/I

(22,095)

1,010,525

-

SR. VP, GENERAL COUNSEL & SEC.

• – –

2023-11-13

4

AS

$52.03

$13,008

D/D

(250)

37,549

-

Mutz Christopher

HEAD OF RARE DISEASE

• – –

2023-11-10

4

S

$52.47

$157,410

D/D

(3,000)

63,607

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-10-19

4

AS

$57.06

$570,600

I/I

(10,000)

1,032,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-10-18

4

AS

$57.78

$360,663

I/I

(6,242)

1,042,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-10-17

4

AS

$58.53

$512,606

I/I

(8,758)

1,048,862

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-10-16

4

AS

$58.31

$761,704

I/I

(13,063)

1,057,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-10-13

4

AS

$57.58

$687,332

I/I

(11,937)

1,070,683

-

SVP - CORP. DEV. & STRATEGY

• – –

2023-10-02

4

AS

$56.48

$1,129,600

I/I

(20,000)

293,226

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-09-19

4

AS

$61.23

$1,551,140

I/I

(25,333)

1,082,620

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-09-18

4

AS

$61.64

$519,317

I/I

(8,425)

1,107,953

-

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

• • –

2023-09-15

4

AS

$62.81

$1,020,160

I/I

(16,242)

1,116,378

-

SVP, CHIEF HR OFFICER

• – –

2023-09-12

4

D

$61.91

$91,998

D/D

(1,486)

35,209

-

722 Records found	1 2 3 4 5 6 7 8 9 Next	Page 4 of 29

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.